PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC – Trademark Portfolio
Entity Type: 16
PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include ETHOSYNTHESIS, ENDOGENOUS LEADERSHIP, and ACHIEVE THE IMPOSSIBLE. ROUTINELY.. The owner is based in Saint Petersburg, FL.
609 11th Ave S.
Saint Petersburg, FL 33701
Showing of trademarks Trademarks
Trademark Classifications
PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC have?
PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC file in?
PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.
What are PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC's most well-known trademarks?
PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC's registered trademark portfolio includes well-known marks such as ETHOSYNTHESIS, ENDOGENOUS LEADERSHIP, and ACHIEVE THE IMPOSSIBLE. ROUTINELY.. These are among 3 currently registered trademarks in the portfolio.
What is PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC's trademark registration success rate?
PHALANX STRATEGIC SOLUTIONS INTERNATIONAL, LLC has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.